Kelly M Hensley

3PUBLICATIONS

44CO-AUTHORS

Molecular targetsGlycoconjugates

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 28, 2026

PF-08046876, a differentiated integrin beta-6 antibody-drug conjugate delivering a potent camptothecin payload optimized for bystander effect and reduced drug efflux.

|Sep 18, 2023

HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer.

Devra Olson, Janelle Taylor, Kelsi Willis

|Feb 17, 2023

SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models.

Rebecca Mazahreh, Marsha L Mason, John J Gosink

Pageof 1

Frequent Collaborators

3 joint publications

Devra Olson

2 joint publications

Sean Allred

2 joint publications

Robert Thurman

2 joint publications

Lori Westendorf

2 joint publications

Rebecca Mazahreh

1 joint publications

Janelle Taylor

1 joint publications

Kelsi Willis

1 joint publications

Margo Zaval

1 joint publications

Sharsti Sandall

1 joint publications

Nishi Jain

Frequent Collaborators

3 joint publications

Devra Olson

2 joint publications

Sean Allred

2 joint publications

Robert Thurman

2 joint publications

Lori Westendorf